Cost-Utility Analysis of a National Hypertension Program in Israel
Author Information
Author(s): Chaim Yosefy, Gary Ginsberg, Reuven Viskoper, Dror Dicker, Dov Gavish
Primary Institution: The Israeli Forum for Prevention of Cardiovascular Disease, Barzilai Medical Center Campus Ashkelon, Ben-Gurion University, Israel
Hypothesis
This study aims to calculate the health effects and costs of a proposed national hypertension prevention and control program.
Conclusion
The project which saves both lives and resources should be extended nation-wide to reach as wide a population as possible.
Supporting Evidence
- The program is expected to save around 2,242 lives over 20 years.
- It will reduce the risk of cardiovascular events by significant percentages.
- The total savings from reduced medical treatment exceed the program costs by $185 million.
Takeaway
This study shows that a national program to help people with high blood pressure can save lives and money.
Methodology
The study used cost-utility analysis based on data from two previous hypertension programs in Israel.
Potential Biases
The model may underestimate benefits by not accounting for long-term mortality beyond one year post-hospitalization.
Limitations
The study relies on current estimates of relative risk and demographics to project future disease incidence.
Participant Demographics
Subjects were aged 25-64 years, with a mean age of 51 years.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website